News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
76 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21249)
Month
January (2935)
February (2968)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
1 (150)
2 (126)
3 (95)
5 (29)
6 (105)
7 (106)
8 (131)
9 (140)
10 (84)
13 (72)
14 (99)
15 (146)
16 (136)
17 (106)
19 (47)
20 (160)
21 (172)
22 (150)
23 (144)
24 (76)
26 (1)
27 (133)
28 (187)
29 (139)
30 (128)
31 (202)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
31
Press Releases
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
October 24, 2025
·
1 min read
Press Releases
Moderna Named a Top Employer by Science for Eleventh Consecutive Year
October 24, 2025
·
3 min read
Press Releases
Zenocutuzumab-zbco Granted FDA Breakthrough Therapy Designation for NRG1+ Cholangiocarcinoma; Data Highlighting Potential of Zenocutuzumab-zbco in NRG1+ Cholangiocarcinoma to be Presented at AACR-NCI-EORTC
October 24, 2025
·
12 min read
Press Releases
Greenstone Biosciences and Illumina announce collaboration to advance precision drug discovery
October 24, 2025
·
1 min read
Press Releases
NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control
October 24, 2025
·
5 min read
Press Releases
Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production
October 24, 2025
·
4 min read
Press Releases
New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference
October 24, 2025
·
8 min read
Press Releases
Vistin Pharma ASA: Invitation to Q3 2025 conference call
October 24, 2025
·
1 min read
Press Releases
Global Launch Event for iza-bren Phase III Nasopharyngeal Carcinoma Research Results Successfully Held, Streamed on ESMO Official Website
October 24, 2025
·
14 min read
CAR-T
Regeneron Cans 2seventy-Acquired CAR T Candidate for Lymphoma in ‘Strategic’ Move
The discontinued CAR T therapy bbT369 came to Regeneron when the pharma bought all of 2seventy bio’s pipeline assets for $5 million upfront in January 2024.
October 24, 2025
·
2 min read
·
Tristan Manalac
Previous
7 of 8
Next
